Closing the loop: the adicol experience.

Simple item page
dc.contributor.authorHovorka, Roman
dc.contributor.authorChassin, Ludovic J
dc.contributor.authorWilinska, Malgorzata E
dc.contributor.authorCanonico, Valentina
dc.contributor.authorAkwi, Joyce Akwe
dc.contributor.authorFederici, Marco Orsini
dc.contributor.authorMassi-Benedetti, Massimo
dc.contributor.authorHutzli, Ivo
dc.contributor.authorZaugg, Claudio
dc.contributor.authorKaufmann, Heiner
dc.contributor.authorBoth, Marcel
dc.contributor.authorVering, Thomas
dc.contributor.authorSchaller, Helga C
dc.contributor.authorSchaupp, Lukas
dc.contributor.authorBodenlenz, Manfred
dc.contributor.authorPieber, Thomas R
dc.date.accessioned2020-02-06T16:02:44Z
dc.date.available2020-02-06T16:02:44Z
dc.date.issued2004-06-16
dc.description.abstractThe objective of the project Advanced Insulin Infusion using a Control Loop ADICOL was to develop a treatment system that continuously measures and controls the glucose concentration in subjects with type 1 diabetes The modular concept of the ADICOL s extracorporeal artificial pancreas consisted of a minimally invasive subcutaneous glucose system a handheld PocketPC computer and an insulin pump D Tron Disetronic Burgdorf Switzerland delivering subcutaneously insulin lispro The present paper describes a subset of ADICOL activities focusing on the development of a glucose controller for semi closed loop control an in silico testing environment clinical testing and system integration An incremental approach was adopted to evaluate experimentally a model predictive glucose controller A feasibility study was followed by efficacy studies of increasing complexity The ADICOL project demonstrated feasibility of a semi closed loop glucose control during fasting and fed conditions with a wearable modular extracorporeal artificial pancreas
dc.identifier.urihttp://dx.doi.org/10.1089/152091504774197990
dc.identifier.urihttps://lib.digitalsquare.io/xmlui/handle/123456789/2017
dc.relation.uriDiabetes technology And therapeutics
dc.titleClosing the loop: the adicol experience.en
dcterms.abstractThe objective of the project Advanced Insulin Infusion using a Control Loop ADICOL was to develop a treatment system that continuously measures and controls the glucose concentration in subjects with type 1 diabetes The modular concept of the ADICOL s extracorporeal artificial pancreas consisted of a minimally invasive subcutaneous glucose system a handheld PocketPC computer and an insulin pump D Tron Disetronic Burgdorf Switzerland delivering subcutaneously insulin lispro The present paper describes a subset of ADICOL activities focusing on the development of a glucose controller for semi closed loop control an in silico testing environment clinical testing and system integration An incremental approach was adopted to evaluate experimentally a model predictive glucose controller A feasibility study was followed by efficacy studies of increasing complexity The ADICOL project demonstrated feasibility of a semi closed loop glucose control during fasting and fed conditions with a wearable modular extracorporeal artificial pancreas
dcterms.contributorHovorka, Roman
dcterms.contributorChassin, Ludovic J
dcterms.contributorWilinska, Malgorzata E
dcterms.contributorCanonico, Valentina
dcterms.contributorAkwi, Joyce Akwe
dcterms.contributorFederici, Marco Orsini
dcterms.contributorMassi-Benedetti, Massimo
dcterms.contributorHutzli, Ivo
dcterms.contributorZaugg, Claudio
dcterms.contributorKaufmann, Heiner
dcterms.contributorBoth, Marcel
dcterms.contributorVering, Thomas
dcterms.contributorSchaller, Helga C
dcterms.contributorSchaupp, Lukas
dcterms.contributorBodenlenz, Manfred
dcterms.contributorPieber, Thomas R
dcterms.identifierhttp://dx.doi.org/10.1089/152091504774197990
dcterms.relationDiabetes technology And therapeutics
dcterms.titleClosing the loop: the adicol experience.en
Files
Collections
mhealth Evidence